Activation of imidazoline receptor by agmatine to lower plasma glucose in streptozotocin-induced diabetic rats

Neuroscience Letters

Volumn 358, Issue 2, 2004, Pages 111-114

  Jou, Shuo Bin ^a   Liu, I Min ^b   Cheng, Juei Tang ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Agmatine; I2 Imidazoline receptors; Spinal cord truncation; Sstreptozotocin induced diabetic rats

Indexed keywords

2 (2 IMIDAZOLIN 2 YL)QUINOLINE; AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; GLUCOSE; IMIDAZOLINE RECEPTOR; INSULIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

AGMATINE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; RECEPTORS, DRUG;

EID: 1542509415     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.01.011     Document Type: Article

References (18)

1. 2-imidazoline ligands. Br. J. Pharmacol. 125:1998;175-185.
2. Chang T.K., Niu C.S., Cheng J.T. Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment. Neurosci. Lett. 218:1996;161-164.
3. Cheng J.T., Liu I.M., Chi T.C., Tzeng T.F., Lu F.H., Chang C.J. Plasma glucose lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 50:2001;2815-2821.
4. Dunne M.J., Harding E.A., Jaggar J.H., Squires P.E., Liang R., Kane C., James R.F., London N.J. Potassium channels, imidazolines, and insulin-secreting cells. Ann. N. Y. Acad. Sci. 763:1995;243-261.
5. Eglen R.M., Hudson A.L., Kendall D.A., Nutt D.J., Morgan N.G., Wilson V.G., Dillon M.P. 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol. Sci. 19:1998;381-390.
6. Hanson R.W., Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu. Rev. Biochem. 66:1997;581-611.
7. Jou I.M. Effects of core body temperature on changes in spinal somatosensory-evoked potential in acute spinal cord compression injury: an experimental study in the rat. Spine. 25:2000;1878-1885.
8. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 263:1994;966-969.
9. Michel M.C., Ernsberger P. Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci. 13:1992;369-370.
10. Morgan N.G., Chan S.L., Mourtada M., Monks L.K., Ramsden C.A. Imidazolines and pancreatic hormone secretion. Ann. N. Y. Acad. Sci. 881:1999;217-228.
11. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18.
12. Raasch W., Schafer U., Chun J., Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br. J. Pharmacol. 133:2001;755-780.
13. Raasch W., Schafer U., Qadri F., Dominiak P. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br. J. Pharmacol. 135:2002;663-672.
14. Reid J.L., Panfilov V., MacPhee G., Elliott H.L. Clinical pharmacology of drugs acting on imidazoline and adrenergic receptors. Studies with clonidine, moxonidine, rilmenidine, and atenolol. Ann. N. Y. Acad. Sci. 763:1995;673-678.
15. Sanchez-Blazquez P., Boronat M.A., Olmos G., Garcia-Sevilla J.A., Garzon J. Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. Br. J. Pharmacol. 130:2000;146-152.
16. Schulz A., Hasselblatt A. Dual action of clonidine on insulin release: suppression, but stimulation when alpha 2-adrenoceptors are blocked. Naunyn-Schmiedeberg's Arch. Pharmacol. 340:1989;712-714.
17. Wasserman D.H., Zinman B. Exercise in individuals with IDDM. Diabetes Care. 17:1994;924-937.
18. Wohaieb S.A., Godin D.V. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effect of insulin treatment. Diabetes. 36:1987;1014-1018.